← FDA Drug Approvals (Drugs@FDA)

GEFITINIB

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: NATCO · Approved 2023-05-31

Drug application

FDA Application #

ANDA212827

Application type

Abbreviated New Drug Application (Generic)

Brand name

GEFITINIB

Generic name

GEFITINIB

Active ingredients

GEFITINIB

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

NATCO

Manufacturer

Natco Pharma USA LLC

First approval

2023-05-31

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown